Concepedia

Victoria Segro

VS

Statistics

Publications

2

Citations

133

H-Index

2

Active since

2018

Affiliations

George Huntington Institute(Current)

University of Münster

University of Tübingen

Teva Pharmaceuticals (Israel)

Hertie Institute for Clinical Brain Research

Victoria Segro is an author at George Huntington Institute specializing in neurology, medicine, and rehabilitation.

Top concepts

Publications per year

2018–2024

2

Publications

2

Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study

Ralf Reilmann, Andrew McGarry, Igor D. Grachev et al. · The Lancet Neurology · 2018 · 104 citations

, , +6

Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 study

Ralf Reilmann, Karen E. Anderson, Andrew Feigin et al. · The Lancet Neurology · 2024 · 29 citations · Full text

, , +2

1–2 of 2